APA (7th ed.) Citation

Akkaif, M. A., Daud, N. A. A., Noor, D. A. M., Sha’aban, A., Kader, M. A. S. A., & Ibrahim, B. (2025). The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI). Cardiovascular Drugs and Therapy, 39(2), 347-356. https://doi.org/10.1007/s10557-024-07544-6

Chicago Style (17th ed.) Citation

Akkaif, Mohammed Ahmed, Nur Aizati Athirah Daud, Dzul Azri Mohamed Noor, Abubakar Sha’aban, Muhamad Ali SK Abdul Kader, and Baharudin Ibrahim. "The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) Among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI)." Cardiovascular Drugs and Therapy 39, no. 2 (2025): 347-356. https://doi.org/10.1007/s10557-024-07544-6.

MLA (9th ed.) Citation

Akkaif, Mohammed Ahmed, et al. "The Impact of CYP2C19 Genotype on the Platelet Reactivity Index (PRI) Among Chronic Coronary Syndromes (CCS) Patients Undergoing Percutaneous Coronary Intervention (PCI)." Cardiovascular Drugs and Therapy, vol. 39, no. 2, 2025, pp. 347-356, https://doi.org/10.1007/s10557-024-07544-6.